en · de · es · fr · pt
tb-500-notes.peptides9000.com › Wiki › Identity And Research Background — Quick Reference

Identity And Research Background — Quick Reference

By Editorial Desk · published 2026-06-06 · last reviewed 2026-06-23 · Wiki

TB-500 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-06-23. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity and Research Background

TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.

Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.

Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.

Identity and Reported Background

Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.

TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.

Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.

Tb-500 at a glance

PropertyValueNotes
Molecular formulaC38H68N10O14Acetylated heptapeptide form
Monoisotopic mass888.5 DaAverage mass about 889 Da
AppearanceWhite to off-white solidUsually supplied as lyophilised powder
Solubility classHighly water solubleAlso dissolves in aqueous buffers
Common synonymsTbeta4 fragment, thymosin beta-4 (17-23)Refer to the same sequence

Research Framing and Evidence Base

Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.

Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.

Related pages on this site

TB-500 Identity and Naming Background

TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.

Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.

Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.

Supporting material

== Non-enzymatic transamination == A second type of transamination reaction can be described as a nucleophilic substitution of one amine or amide anion on an amine or ammonium salt. For example, the attack of a primary amine by a primary amide anion can be used to prepare secondary amines:

The virus has been used for cyber warfare against the national oil companies Saudi Aramco and Qatar's RasGas. Saudi Aramco announced the attack on their Facebook page and went offline again until a company statement was issued on 25 August 2012. The statement falsely reported normal business was resumed on 25 August 2012. However a Middle Eastern journalist leaked photographs taken on 1 September 2012 showing kilometers of petrol trucks unable to be loaded due to backed business systems still inoperable. On 29 August 2012 the same attackers behind Shamoon posted another pastie on PasteBin.com, taunting Saudi Aramco with proof they still retained access to the company network. The post contained the username and password on security and network equipment and the new password for the CEO Khalid Al- Falih The attackers also referenced a portion of the Shamoon malware as further proof in the pastie. According to Kubecka, in order to restore operations. Saudi Aramco used its large private fleet of aircraft and available funds to purchase much of the world's hard drives, driving the price up. New hard drives were required as quickly as possible so oil prices were not affected by speculation. By 1 September 2012 gasoline resources were dwindling for the public of Saudi Arabia 17 days after the 15 August attack. RasGas was also affected by a different variant, crippling them in a similar manner.

=== Pregnancy === In women with known hypothyroidism who become pregnant, it is recommended that serum TSH levels are closely monitored. Levothyroxine should be used to keep TSH levels within the normal range for that trimester. The first-trimester normal range is below 2.5 mIU/L and the second and third trimesters normal range is below 3.0 mIU/L. Measurement of free T4 in pregnancy is not recommended due to changes in levels of serum protein binding. Similarly to TSH, the thyroxine results should be interpreted according to the appropriate reference range for that stage of pregnancy. The levothyroxine dose often needs to be increased after pregnancy is confirmed, although this is based on limited evidence and some recommend that it is not always required; decisions may need to based on TSH levels. Women with anti-TPO antibodies who are trying to become pregnant (naturally or by assisted means) may require thyroid hormone supplementation even if the TSH level is normal. This is particularly true if they have had previous miscarriages or have been hypothyroid in the past. Supplementary levothyroxine may reduce the risk of preterm birth and possibly miscarriage. The recommendation is stronger in pregnant women with subclinical hypothyroidism (defined as TSH 2.5–10 mIU/L) who are anti-TPO positive, in view of the risk of overt hypothyroidism. If a decision is made not to treat, close monitoring of the thyroid function (every 4 weeks in the first 20 weeks of pregnancy) is recommended.

Sources: en.wikipedia.org

Supporting material

=== Iranian plan === Cessation of the war on Iraq, Lebanon, and Yemen Cessation of the war in Iran with no time limit Ending all conflicts in the region Reopening the Strait of Hormuz Establishing a protocol and conditions to ensure freedom and security of navigation in the Strait Full payment of war reparations to Iran Lifting sanctions on Iran Release of the Iranian frozen assets held by the United States Iran commits to not seeking possession of any nuclear weapons Immediate ceasefire on all fronts upon the ceasefire announcement Further complicating matters, Iran released several different version of the plan, with small differences, and differences between the Persian and English versions.

Tarlov concluded that such cysts, though often overlooked during standard imaging or surgery, could produce clinically significant symptoms and should be considered in cases of unexplained sciatic pain. He published these findings in the paper "Cysts (Perineurial) of the Sacral Roots: Another Cause (Removable) of Sciatic Pain" (1948). In 1952, Tarlov published his third paper on perineurial cysts, titled "Cysts of the Sacral Nerve Roots: Clinical Significance and Pathogenesis". In this work, he acknowledged the limitations of his earlier cadaver studies due to incomplete medical records, noting that the symptomatic relevance of the cysts was initially unclear. The paper presented detailed accounts of two surgical cases from 1950 and 1951 in which sacral nerve root cysts were associated with neurological symptoms. The first patient, a 28-year-old man with progressive numbness, urinary incontinence, and sexual dysfunction, was found to have bilateral S2 cysts; surgical removal of the right cyst and drainage of the left halted symptom progression and improved bladder function. The second case involved a 70-year-old woman with paresthesia in the right leg and vaginal area, foot weakness, and sacral tenderness, in whom four cysts were discovered on the S2 and S3 nerve roots. Partial excision led to improvement in foot strength and partial symptom relief. Tarlov also discussed two post-mortem cases in which subarachnoid hemorrhages and sacral cysts coexisted, prompting the hypothesis that the cysts might occasionally form secondary to hemorrhagic damage to nerve roots.

=== Counting methods === In order to quantify the number of substitutions, one may reconstruct the ancestral sequence and record the inferred changes at sites (straight counting – likely to provide an underestimate); fitting the substitution rates at sites into predetermined categories (Bayesian approach; poor for small data sets); and generating an individual substitution rate for each codon (computationally expensive). Given enough data, all three of these approaches will tend to the same result.

=== Physical === Most of the physical properties of astatine have been estimated (by interpolation or extrapolation), using theoretically or empirically derived methods. For example, halogens get darker with increasing atomic weight—fluorine is nearly colorless, chlorine is yellow-green, bromine is red-brown, and iodine is dark gray/violet. Astatine is sometimes described as probably being a black solid (assuming it follows this trend), or as having a metallic appearance (if it is a metalloid or a metal). Because it has a lower vapor pressure than iodine, astatine sublimes, as expected. Half of a given quantity of astatine will vaporize in approximately an hour if put on a clean glass surface at room temperature. The absorption spectrum of astatine in the middle ultraviolet region has lines at 224.401 and 216.225 nm, suggestive of 6p to 7s transitions. The structure of solid astatine is unknown. As an analog of iodine it may have an orthorhombic crystalline structure composed of diatomic astatine molecules, and be a semiconductor (with a band gap of 0.7 eV). Alternatively, if condensed astatine forms a metallic phase, as has been predicted, it may have a monatomic face-centered cubic structure; in this structure, it may well be a superconductor, like the similar high-pressure phase of iodine. Metallic astatine is expected to have a density of 8.91–8.95 g/cm3. Evidence for (or against) the existence of diatomic astatine (At2) is sparse and inconclusive.

Sources: en.wikipedia.org

Notes from published material

Secret police and armed forces were ordered to initiate large-scale incursions into the houses of protest planners and independent journalists "once each sector has been cleansed of wanted people", Ba'athist paramilitaries were to occupy these areas under protection of Syrian military and prevent survivors from returning to their homes Formation of "joint investigation committees" headed by leaders of the Baathist security departments across all provinces to incarcerate suspected activists and cross-examining them in prisons Transfer of the findings across all security branches for pinpointing of additional suspects The commands were passed down to the provincial leaders of the party who were instructed to swiftly execute the orders in their respective regions

== Honors and awards == Diamandis is a member of the Academy of Athens and the Royal Society of Canada. He is also a fellow of the American Association for the Advancement of Science, the Canadian Academy of Health Sciences, and the Royal College of Physicians and Surgeons of Canada. From the American Association for Clinical Chemistry, he has received the Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics, among other awards; he is also a member of the Association's Hall of Fame.

=== Laboratory synthesis === As early as the 1860s, experiments demonstrated that biologically relevant molecules can be produced from interaction of simple carbon sources with abundant inorganic catalysts. The spontaneous formation of complex polymers from abiotically generated monomers under the conditions posited by the "soup" theory is not straightforward. Besides the necessary basic organic monomers, compounds that would have prohibited the formation of polymers were also formed in high concentration during the Miller–Urey experiment and Joan Oró experiments. Biology uses essentially 20 amino acids for its coded protein enzymes, representing a very small subset of the structurally possible products. Since life tends to use whatever is available, an explanation is needed for why the set used is so small. Formamide is attractive as a medium that potentially provided a source of amino acid derivatives from simple aldehyde and nitrile feedstocks.

Sources: en.wikipedia.org

Frequently asked questions

Is TB-500 the same as thymosin beta-4?

No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.

What amino acids make up this peptide?

It consists of leucine, lysine, lysine, threonine, glutamic acid, threonine, and glutamine in that order. The N-terminal leucine is usually acetylated in the forms described in catalogues.

How much human data exists for this sequence?

Controlled human data is limited, and most published findings come from cell culture or animal work. This makes it difficult to state clinical effects with confidence.

What is TB-500 made of?

Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.

Network